Atlantic International Corp.

NASDAQ:ATLN

Medical - Diagnostics & Research

Healthcare
$0.90 -13.84%

-$0.10 today

Market cap
$73.17M
Beta
0.71
P/E (TTM)
-0.6
EPS (TTM)
-$1.08
52W Low $0.60High $5.25

Volume 18.56M

Average 0.44M

ATLN Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Atlantic International Corp.NASDAQ: ATLN

Accounts Receivables · Q4 FY2025 · quarter ended Dec 2025

Accounts receivables dips below year-ago levels

Q4 FY2025 accounts receivables of $4.22M (cash outflow) fell 69.2% year over year, behind the +128.6% change in trailing-twelve-month accounts receivables. Sequentially, it rose 1.0% from the prior quarter.

Context

  • Accounts receivables amounted to 0.6% of revenue in FY2025, down 1.7 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -69.2% toward the trailing-twelve-month pace of +128.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
-$4.22M+1.0% QoQ
Last fiscal yearDec 2025
$2.41M+124.3% YoY
LTMDec 2025
$2.84M+128.6% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-69.2%——
1 year+124.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
2.41M USD
Year-over-year change
+124.3%
4-year CAGR
+139.1%

Accounts Receivables vs competitors

How ATLN compares with its peers on the latest reported figures

  • ATLN's LTM Dec 2025 accounts receivables of $2.84M is the 4th largest of the 8 companies compared; the peer median is $0.
  • Its year-over-year change of +128.6% is the 4th highest of 5, against a peer median of +247.4%.
  • Accounts receivables amounts to 0.7% of revenue for ATLN, versus a peer median of 61.1%.
ATLN Competitors Peer median
Accounts Receivables for ATLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
STIMNeuronetics, Inc.LTM Mar 2026$7.18M +294.6%—4.7%
IMDXInsight Molecular Diagnostics Inc.LTM Mar 2026$3.38M +200.1%—173.6%
MISTMilestone Pharmaceuticals Inc.LTM Mar 2026$2.85M +7601.5%+15.2%159.7%
ATLNAtlantic International Corp.LTM Dec 2025$2.84M +128.6%—0.7%
AVRAnteris Technologies Global Corp.LTM Mar 2026$1.13M +23.8%-1.2%61.1%
PREPrenetics Global LimitedLTM Mar 2026$74K ——0.1%
NKTXNkarta, Inc.LTM Mar 2026$0 ———
PEPGPepGen Inc.LTM Mar 2026$0 ———
Peer median (excluding ATLN) $0+247.4%+7.0%61.1%

Competitors are the stored peer set for ATLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(3.7M)(4.09M)(15.25M)(135.48M)(59.43M)
Depreciation & Amortization86.44K87.94K5.04M4.99M210.5K
Deferred Income Tax00(5.14M)5.24M0
Stock-Based Compensation333.98K256.9K045.2M36.14M
Change in Working Capital119.96K(155.38K)204.34K15.95M10.22M
Accounts Receivables73.85K(15.54K)(384.28K)(9.92M)2.41M
Inventory(21.14K)(20.71K)000
Accounts Payables9.52K(248.93K)631.86K1.23M3.08M
Other Working Capital57.73K129.79K(43.24K)24.64M4.72M
Other Non-Cash Items1.17M242.81K6.07M58.11M8.47M
Operating Cash Flow(1.99M)(3.66M)(9.08M)(5.99M)(4.4M)
Capital Expenditures(14.47K)(40.02K)(73.71K)(73.46K)(66.77K)
Acquisitions (Net)00000
Purchases of Investments(5.98M)(4.01M)(2.8M)00
Sales of Investments05.88M6.92M00
Other Investing Activities00(4.12M)00
Investing Cash Flow(5.99M)1.83M(73.71K)(73.46K)(66.77K)
Debt Repayment(187.89K)08.83M(962.48K)3.87M
Common Stock Issued13.81M01.8M00
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.63M)0(1.84M)6.35M0
Financing Cash Flow12M08.79M5.38M3.87M
Effect of Forex Changes00000
Net Change in Cash4.02M(1.83M)(363.23K)(674.25K)(597.54K)
Free Cash Flow(2M)(3.7M)(9.16M)(6.06M)(4.46M)

Atlantic International Corp.

NASDAQ:ATLN

Intrinsic Alpha fair value

Locked

Current Price

$0.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.